These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37272801)

  • 1. Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein.
    Chen F; Park HR; Ji HJ; Kwon Y; Kim MK; Song JY; Ahn KB; Seo HS
    Microbiol Spectr; 2023 Aug; 11(4):e0135823. PubMed ID: 37272801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease.
    Lin M; Zhang W; Yin YF; Si JY; Zhang LJ; Chen L; Lin X; Wang YB; Zhang J; Zheng ZZ; Xia NS
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    Wang Y; Ge F; Wang J; Li H; Zheng B; Li W; Chen S; Zheng X; Deng Y; Wang Y; Zeng R
    J Virol; 2023 Mar; 97(3):e0176422. PubMed ID: 36779760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Schneider-Ohrum K; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; Cheng LI; O'Day T; Cayatte C
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide Inhibits FI-RSV Vaccine-enhanced Inflammation Through Regulating Th Responses.
    Yin W; Li HY; Zheng BY; Deng YQ; Li WJ; Liu Y; Zeng RH
    Curr Med Sci; 2019 Jun; 39(3):363-370. PubMed ID: 31209804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs.
    Zhang L; Li H; Hai Y; Yin W; Li W; Zheng B; Du X; Li N; Zhang Z; Deng Y; Zeng R; Wei L
    J Virol; 2017 May; 91(10):. PubMed ID: 28275186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Hwang HS; Lee YT; Kim KH; Ko EJ; Lee Y; Kwon YM; Kang SM
    Virology; 2017 Nov; 511():142-151. PubMed ID: 28846899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
    Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
    Frenkel LD; Gaur S; Bellanti JA
    Allergy Asthma Proc; 2023 Jul; 44(4):220-228. PubMed ID: 37236777
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro model for the assessment of human immune responses to subunit RSV vaccines.
    Chirkova T; Ha B; Rimawi BH; Oomens AGP; Hartert TV; Anderson LJ
    PLoS One; 2020; 15(3):e0229660. PubMed ID: 32191728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.
    Killikelly AM; Kanekiyo M; Graham BS
    Sci Rep; 2016 Sep; 6():34108. PubMed ID: 27682426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
    Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
    Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
    Johnson TR; Varga SM; Braciale TJ; Graham BS
    J Virol; 2004 Aug; 78(16):8753-60. PubMed ID: 15280483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Jung YJ; Lee Y; Lee JS; Lee YN; Park S; Kang SM
    PLoS One; 2015; 10(10):e0139916. PubMed ID: 26468884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
    Huang JM; Wang SY; Lai MR; Tseng YK; Chi YH; Huang LM
    Vaccine; 2021 Jun; 39(24):3259-3269. PubMed ID: 33972124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.